Home » HealthNews
Combo Cancer Drugs Outperform Chemo Alone in Key Breast Cancer Subgroups

Combo Cancer Drugs Outperform Chemo Alone in Key Breast Cancer Subgroups

Recent research presented at the European Society for Medical Oncology (ESMO) meeting shows that antibody-drug conjugates (ADCs) significantly improve outcomes for certain breast cancer patients when used alongside chemotherapy. For patients with aggressive triple-negative breast cancer who cannot get immunotherapy, Trodelvy extended median progression-free survival to 9.7 months, compared to 6.9 months with standard chemo….

Read More
FDA okays Amgen/AstraZeneca’s Tezspire for teen and adult sinus-polyp disease.

FDA Approves Amgen & AstraZeneca’s Drug for Severe Sinus Condition in Teens and Adults

The U.S. Food and Drug Administration (FDA) has expanded approval for Tezspire (tezepelumab-ekko), a drug co-developed by Amgen and AstraZeneca. Starting now, it can be used as a maintenance treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in people aged 12 and older.  CRSwNP is a long-term sinus condition featuring inflammation and non-cancerous growths called…

Read More